Precision BioSciences, Inc.
DTIL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $86 | $117 | $190 | $144 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $2 | $13 | $1 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $7 | $7 | $9 | $18 |
| Total Curr. Assets | $95 | $136 | $199 | $162 |
| Property Plant & Equip (Net) | $10 | $15 | $14 | $29 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1 | $0 | $1 | $2 |
| Long-Term Investments | $3 | $3 | $5 | $7 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $27 | $5 | $20 | $12 |
| Total NC Assets | $41 | $23 | $39 | $50 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $136 | $160 | $238 | $211 |
| Liabilities | – | – | – | – |
| Payables | $1 | $3 | $1 | $1 |
| Short-Term Debt | $1 | $24 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $3 | $12 | $46 | $21 |
| Other Curr. Liab. | $9 | $11 | $11 | $12 |
| Total Curr. Liab. | $15 | $50 | $60 | $36 |
| LT Debt | $29 | $8 | $23 | $7 |
| Deferred Rev, NC | $33 | $83 | $93 | $77 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3 | $0 | $2 | $0 |
| Total NC Liab. | $65 | $91 | $118 | $84 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $8 | $9 | $3 | $7 |
| Total Liabilities | $80 | $141 | $178 | $120 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$482 | -$490 | -$428 | -$317 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $539 | $508 | $489 | $408 |
| Total Equity | $56 | $19 | $60 | $91 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $136 | $160 | $238 | $211 |
| Net Debt | -$56 | -$85 | -$165 | -$135 |